Marksans Pharma Limited hereby announces that USFDA has granted approval for an Abbreviated New Drug Application (ANDA) for Paricalcitol Capsules 1 meg, 2 meg and 4 meg.
Paricalcitol Capsules 1 meg, 2 meg and 4 meg are therapeutically equivalent to the reference listed drug Zemplar Capsules 1 meg, 2 meg and 4 meg of Abbvie Inc.
Paricalcitol is a Synthetic Vitamin D analog. Vitamin D is important for the absorption of Calcium from the stomach and for the functioning of Calcium in the body. Paricalcitol is used to treat or prevent hyper parathyroidism (overactive para thyroid gland). It has been used to reduce parathyroid hormone level.
Subscribe to PharmaTutor News Alerts by Email
